戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              IkappaBbeta degradation releases NF-kappaB dimers which
2                                              IkappaBbeta derives its high affinity toward NF-kappaB d
3                                              IkappaBbeta expression in haploid spermatids is likely r
4                                              IkappaBbeta is a member of the IkappaB family of structu
5                                              IkappaBbeta mRNA knock down also reduced resistance to s
6                                              IkappaBbeta mRNA knock down selectively abrogated the re
7                                              IkappaBbeta, a major isoform of IkappaB, can sequester N
8                                              IkappaBbeta, one of the major IkappaB proteins, is only
9  that mitochondrial stress signaling uses an IkappaBbeta-initiated NFkappaB pathway that is distinct
10 ct with the PEST domains of IkappaBalpha and IkappaBbeta [inhibitors of the transcription factor nucl
11 ase interacts with cellular IkappaBalpha and IkappaBbeta and cleaves them.
12 iae, induced degradation of IkappaBalpha and IkappaBbeta and rapid nuclear accumulation of RelA.
13 gradation of the inhibitors IkappaBalpha and IkappaBbeta and the concomitant release of NF-kappaB.
14                             IkappaBalpha and IkappaBbeta are regulators of the nuclear factor-kappaB
15 ecificity of HTLV-1 Tax for IkappaBalpha and IkappaBbeta at the protein level, Tax selectively stimul
16  We show that although both IkappaBalpha and IkappaBbeta bind to NF-kappaB with similar global archit
17  of the inhibitory proteins IkappaBalpha and IkappaBbeta but not IkappaBepsilon.
18                 By inducing IkappaBalpha and IkappaBbeta cleavage and IkappaB kinase activation, DENV
19  of DENV protease to induce IkappaBalpha and IkappaBbeta cleavage and trigger hemorrhage development.
20 nase activation to regulate IkappaBalpha and IkappaBbeta degradation and synthesis, and promote Ikapp
21   Most agents that activate IkappaBalpha and IkappaBbeta degradation do not induce rapid degradation
22  activation at the level of IkappaBalpha and IkappaBbeta degradation.
23        Chimeric analyses of IkappaBalpha and IkappaBbeta further revealed that the ankyrin repeats of
24 ve analyzed the function of IkappaBalpha and IkappaBbeta in breast cancer cells.
25 n induced the expression of IkappaBalpha and IkappaBbeta in thymocytes and down-regulated NF-kappaB D
26  capable of phosphorylating IkappaBalpha and IkappaBbeta in vitro.
27 taneous proteolysis of both IkappaBalpha and IkappaBbeta isoforms; IkappaBgamma is inert to TNFalpha
28 se results demonstrate that IkappaBalpha and IkappaBbeta play unique injury context-specific roles in
29 ists induced an increase in IkappaBalpha and IkappaBbeta protein levels, which was prevented with CD4
30                         The IkappaBalpha and IkappaBbeta proteins inhibit the transcriptional potenti
31 ent down-regulation of both IkappaBalpha and IkappaBbeta proteins, derived from a continuous TNF sign
32 These results indicate that IkappaBalpha and IkappaBbeta share significant similarities in their bioc
33 g either stimulus, only the IkappaBalpha and IkappaBbeta steady-state levels declined in parallel wit
34 red divergent properties of IkappaBalpha and IkappaBbeta that influence their ability to activate hep
35 gue hemorrhage and discover IkappaBalpha and IkappaBbeta to be the new cellular targets that are clea
36                             IkappaBalpha and IkappaBbeta were significantly diminished in RelA-null e
37 ilitated the association of IkappaBalpha and IkappaBbeta with the high molecular weight IKK complex.
38 -kappaB inhibitory proteins IkappaBalpha and IkappaBbeta, resulting in constitutive nuclear expressio
39              In the case of IkappaBalpha and IkappaBbeta, the specific NF-kappaB subunit in the compl
40 e rapid degradation of both IkappaBalpha and IkappaBbeta, two major cytoplasmic inhibitors of NF-kapp
41  related IkappaB molecules, IkappaBalpha and IkappaBbeta, we generated knock-in mice by replacing the
42  two members of the family, IkappaBalpha and IkappaBbeta, which also function in the nucleus to termi
43 led by the IkappaB proteins IkappaBalpha and IkappaBbeta, which restrict NF-kappaB in the cytoplasm a
44 prototypical IkappaBs, like IkappaBalpha and IkappaBbeta.
45 of the NF-kappaB inhibitors IkappaBalpha and IkappaBbeta.
46 complex with its inhibitors IkappaBalpha and IkappaBbeta.
47 lex for both phosphorylated IkappaBalpha and IkappaBbeta.
48 that can each phosphorylate IkappaBalpha and IkappaBbeta.
49 plasmic inhibitory proteins IkappaBalpha and IkappaBbeta.
50 orylated inhibitors such as IkappaBalpha and IkappaBbeta.
51  to the inhibitory proteins IkappaBalpha and IkappaBbeta.
52 ly of inhibitors, including IkappaBalpha and IkappaBbeta.
53 uggested redundancy between IkappaBalpha and IkappaBbeta.
54 lone and in the presence of IkappaBalpha and IkappaBbeta.
55 F-kappaB and the inhibitors IkappaBalpha and IkappaBbeta.
56  by itself binds tightly to IkappaBalpha and IkappaBbeta.
57 accompanied by loss of both IkappaBalpha and IkappaBbeta.
58 s and compared with that of IkappaBalpha and IkappaBbeta.
59  p50, and IkappaB proteins, IkappaBalpha and IkappaBbeta.
60 he inhibitors of NF-kappaB, IkappaBalpha and IkappaBbeta.
61 Balpha (inhibitory subunit of NF-kappaB) and IkappaBbeta, and nuclear translocation of p65.
62 anscript and protein levels of p50, p65, and IkappaBbeta remained relatively unchanged during the cou
63  of NF-kappaB1, NF-kappaB2, RelA, c-Rel, and IkappaBbeta similar to those of wild-type fibroblasts.
64 0 downward arrow, IkappaBalpha upward arrow, IkappaBbeta upward arrow).
65 educed, but not nearly to the same extent as IkappaBbeta, thus highlighting the degree to which Ikapp
66 theses of inhibitors IkappaBalpha as well as IkappaBbeta were restored.
67                         Furthermore, because IkappaBbeta does not undergo nucleocytoplasmic shuttling
68 uctural studies, which predicted that binary IkappaBbeta x NF-kappaB complexes should be capable of n
69                                     Blocking IkappaBbeta might be a promising new strategy for select
70 pitation show that NFkappaB/Rel factor-bound IkappaBbeta forms a ternary complex with Cn under in vit
71 lating growth and survival may be blocked by IkappaBbeta.
72  link the innate immune response mediated by IkappaBbeta/NF-kappaB to ET-1 expression and potentially
73 tivated HIV in both U1 and J-Lat 10.6 cells, IkappaBbeta knockdown did not activate HIV, and, surpris
74  regulate the inhibitory NF-kappaB component IkappaBbeta.
75 decreased NF-kappaB activity and concomitant IkappaBbeta accumulation and that these defects were ame
76                                Consequently, IkappaBbeta protein expression is chronically downregula
77 nuclear localization signal clearly contacts IkappaBbeta, whereas a homologous segment from the secon
78                                 In contrast, IkappaBbeta is nearly completely degraded during the acu
79                         Although cytoplasmic IkappaBbeta inhibits activity of cRel-containing NF-kapp
80 rrelated with a reduced level of cytoplasmic IkappaBbeta and could be associated with the overexpress
81 a partial reduction (35 to 40%) in cytosolic IkappaBbeta.
82 al association between PDE8A1 and endogenous IkappaBbeta by an antibody array technique.
83                           Studies evaluating IkappaBbeta knock-in mice (AKBI), in which the IkappaBal
84 ay in oncogenic transformation, we expressed IkappaBbeta, a specific inhibitor of NF-kappaB, in two h
85 E8A1 competed with the p65/p50 NF-kappaB for IkappaBbeta binding.
86  protein in the absence of elevated mRNA for IkappaBbeta.
87 on of NF-kappaB activation that results from IkappaBbeta degradation preserves the enhanced antioxida
88                                 Furthermore, IkappaBbeta was found to exist in both a basally phospho
89 appaB proteins are significantly homologous, IkappaBbeta contains a unique 47-amino acid insertion of
90 PKC and the generation of hypophosphorylated IkappaBbeta.
91 revious observations that hypophosphorylated IkappaBbeta.NF-kappaB complexes can reside in the nucleu
92                 In vitro, hypophosphorylated IkappaBbeta can bind DNA with p65 and c-Rel, and the DNA
93 h the absence of nuclear, hypophosphorylated-IkappaBbeta bound to p65:c-Rel heterodimers at a specifi
94 e-linked immunosorbent assays; IkappaBalpha, IkappaBbeta, and p105 immunoblot analysis; and nuclear f
95 ed in substrates of canonical (IkappaBalpha, IkappaBbeta) and alternative (p100) NF-kappaB pathways,
96 rs: the prototypical IkappaBs (IkappaBalpha, IkappaBbeta, and IkappaBepsilon), which form low-molecul
97      Three canonical IkappaBs, IkappaBalpha, IkappaBbeta, and IkappaBepsilon, exist, but the IkappaB
98 isappearance of immunoreactive IkappaBalpha, IkappaBbeta, IkappaBgamma, or IkappaBepsilon or with the
99 y related inhibitors including IkappaBalpha, IkappaBbeta, and IkappaBepsilon, which trap NF-kappaB in
100 nucleus secondary to increased IkappaBalpha, IkappaBbeta, and IkappaBepsilon degradation, a mechanism
101 TCR/CD28 costimulation induces IkappaBalpha, IkappaBbeta, and IkappaBepsilon degradation, and PKC is
102 kappaB cytoplasmic inhibitors, IkappaBalpha, IkappaBbeta, and IkappaBepsilon, by these kinases trigge
103 all 3 inhibitors of NF-kappaB: IkappaBalpha, IkappaBbeta, and IkappaBepsilon.
104                           Like IkappaBalpha, IkappaBbeta is also inducibly degraded; however, upon st
105 ls express the IkappaB members IkappaBalpha, IkappaBbeta, and IkappaBgamma.
106 of the Bcl-3-related molecules IkappaBalpha, IkappaBbeta, and IkappaBepsilon in SEB-activated T cells
107  to DNA and the degradation of IkappaBalpha, IkappaBbeta, and IkappaBvarepsilon.
108 he IkappaB inhibitory subunits IkappaBalpha, IkappaBbeta, and p105; however, following either stimulu
109      Here we show that, unlike IkappaBalpha, IkappaBbeta and IkappaBepsilon appear to sequester p65 o
110 cytosol with p100 but not with IkappaBalpha, IkappaBbeta, IkappaBepsilon, nor p105.
111                                           In IkappaBbeta, the NLS polypeptide binds to two binding si
112     Substitutions of the homologous sites in IkappaBbeta, serines 19 and 23, also prevent inducible I
113 ces whereas excess kappaB-Ras blocks induced IkappaBbeta degradation.
114 te that NaSal similarly inhibits TNF-induced IkappaBbeta degradation in a p38-dependent manner.
115 a, serines 19 and 23, also prevent inducible IkappaBbeta degradation.
116 novo degradation of the NF-kappaB inhibitor, IkappaBbeta.
117  but not the structurally related inhibitors IkappaBbeta or IkappaBepsilon.
118 appaB regulation exhibited by the inhibitors IkappaBbeta and IkappaBalpha.
119 hat NF-kappaB : IkappaBalpha and NF-kappaB : IkappaBbeta complexes are regulated by different upstrea
120                                    NF-kappaB.IkappaBbeta complex crystals were formed by analogy to N
121 nucleocytoplasmic complex, whereas NF-kappaB.IkappaBbeta complexes are localized to the cytoplasm of
122 ily and imply a potential role for NF-kappaB/IkappaBbeta in spermatogenesis.
123  proteins are associated only with NF-kappaB:IkappaBbeta complexes and therefore may provide an expla
124 h p65 and c-Rel, and the DNA-bound NF-kappaB:IkappaBbeta complexes are resistant to IkappaBalpha, sug
125                       Although cells lacking IkappaBbeta have been reported, in vivo studies have bee
126 o caused similar changes (increases) in lung IkappaBbeta.
127  was associated with elevated levels of lung IkappaBbeta (but not IkappaBalpha) protein in the absenc
128 ugh IkappaBalpha and another IkappaB member, IkappaBbeta, can enter the nucleus and repress NF-kappaB
129 ith a plasmid containing cDNA encoding mouse IkappaBbeta, an inhibitor of NF-kappaB, resulted in incr
130                                    The mouse IkappaBbeta gene contains six exons and five introns tha
131              In the present study, the mouse IkappaBbeta gene was cloned and sequenced, and its struc
132  We report the crystal structure of a murine IkappaBbeta x NF-kappaB p65 homodimer complex.
133 ly, a complex between NF-kappaB and a mutant IkappaBbeta protein containing four serine to alanine mu
134  for IkappaBalpha and IkappaBepsilon but not IkappaBbeta degradation.
135 ces the degradation of IkappaBalpha, but not IkappaBbeta nor an N-terminal deletion mutant of IkappaB
136 the ankyrin repeats of IkappaBalpha, but not IkappaBbeta, contained information necessary for PIR deg
137 hat the specificity of IkappaBalpha, but not IkappaBbeta, to properly regulate NF-kappaB induction du
138 on and a degradation of IkappaBalpha but not IkappaBbeta.
139 of cRel-containing NF-kappaB dimers, nuclear IkappaBbeta stabilizes NF-kappaB/DNA binding and enhance
140 aB p65 homodimer suggest a model for nuclear IkappaBbeta.NF-kappaB.DNA ternary complex formation.
141 lpha, suggesting hypophosphorylated, nuclear IkappaBbeta may prolong the expression of certain genes.
142 verexpress IkappaBbeta, we show that nuclear IkappaBbeta is both necessary and sufficient to drive LP
143                     Surprisingly, absence of IkappaBbeta results in a dramatic reduction of TNF-alpha
144 estigated, little or no detectable amount of IkappaBbeta was found.
145 Like IkappaBalpha, Tax-mediated breakdown of IkappaBbeta in transfected T lymphocytes is blocked eith
146 e findings, we propose that tight control of IkappaBbeta protein by p65 is necessary for the maintena
147  of IkappaBalpha and a sustained decrease of IkappaBbeta that correlated with increased and persisten
148 aB kinase (IKK), resulting in degradation of IkappaBbeta and activation of NF-kappaB.
149 bited the cytoplasmic protein degradation of IkappaBbeta and IkappaBalpha, as well as repressed their
150 ween the proteasome-dependent degradation of IkappaBbeta and the AICD that occurs through activation
151 A through phosphorylation and degradation of IkappaBbeta and the re-expression of NF-kappaB regulated
152                               Degradation of IkappaBbeta and the translocation of the NF-kappaB (p50/
153 of NF-kappaB/Rel by promoting degradation of IkappaBbeta as well as enhancing degradation of IkappaBa
154 nation for the slower rate of degradation of IkappaBbeta compared with IkappaBalpha.
155 hosphorylation and subsequent degradation of IkappaBbeta in both human Jurkat T cells and the murine
156 e revealed that the inducible degradation of IkappaBbeta induced by calyculin A, and TNF-alpha requir
157  PKR-null cells, pIC-mediated degradation of IkappaBbeta is deficient.
158      The calyculin A-mediated degradation of IkappaBbeta is further enhanced by the cytokine tumor ne
159 duced by phorbol ester alone, degradation of IkappaBbeta is largely dependent on the CD28 costimulato
160 served with IkappaBalpha, the degradation Of IkappaBbeta is not associated with its rapid resynthesis
161  the mechanism underlying the degradation of IkappaBbeta remains elusive.
162 onstrate that Tax induces the degradation Of IkappaBbeta, another NF-kappaB/Rel cytoplasmic inhibitor
163 in) in the ubiquitination and degradation of IkappaBbeta, one of the two major IkappaB isoforms in ma
164 tory factor 3 (IRF3) but also degradation of IkappaBbeta, thereby inhibiting IRF3 and NF-kappaB activ
165                   The induced degradation of IkappaBbeta, which is normally observed upon TNF-alpha/I
166 abrogate its ability to block degradation of IkappaBbeta.
167 so required for the inducible degradation of IkappaBbeta.
168 timuli are able to induce the degradation of IkappaBbeta.
169 alone is unable to induce the degradation of IkappaBbeta.
170 re essential for the complete degradation of IkappaBbeta.
171 at T cells leads to the gradual depletion of IkappaBbeta, which is correlated with the induction of c
172 arily associated with long-term depletion of IkappaBbeta.
173 d S315 from the COOH-terminal PEST domain of IkappaBbeta is critical for binding to Cn.
174 s regulated by the C-terminal PEST domain of IkappaBbeta.
175                                Knock down of IkappaBbeta, but not IkappaBalpha, mRNA reduced the mito
176 lly, we have characterized the expression of IkappaBbeta in testis, a tissue in which IkappaBalpha is
177                                Expression of IkappaBbeta significantly reduced NF-kappaB activation i
178                 Interestingly, expression of IkappaBbeta suppressed growth of A549 cells in low serum
179          These unique structural features of IkappaBbeta may contribute to its ability to mediate per
180 xpression of a proteolysis-resistant form of IkappaBbeta, but not IkappaBalpha, causes a severe growt
181 on between ankyrin repeats three and four of IkappaBbeta is mostly disordered in the structure.
182                Specifically, the function of IkappaBbeta in mediating the cellular response to oxidat
183                However, metastatic growth of IkappaBbeta-expressing A549 cells in the lungs of nude m
184 could induce anchorage-independent growth of IkappaBbeta-expressing A549 cells, suggesting that the I
185 es suggest that Tax-mediated inactivation Of IkappaBbeta may play a role in the persistent nuclear ex
186 FkappaB/Rel factors involves inactivation of IkappaBbeta through Cn-mediated dephosphorylation.
187         By contrast, selective inhibition of IkappaBbeta proteolysis by pretreatment of HepG2 cells w
188 ppaBalpha degradation and the lower level of IkappaBbeta turnover during the second phase of the acti
189 s containing Tax had extremely low levels of IkappaBbeta, but not IkappaBalpha, and contained predomi
190 nce of IkappaBbeta in proper localization of IkappaBbeta x NF-kappaB complexes.
191 ibited by an N-terminal truncation mutant of IkappaBbeta that is incapable of responding to the degra
192                            Third, mutants of IkappaBbeta that are defective for phosphorylation at Se
193 able proteasome inhibitors or by mutation Of IkappaBbeta at two serine residues present within its N-
194 ectly blocks the in vitro phosphorylation of IkappaBbeta by IKKbeta.
195 ion is dependent on prior phosphorylation of IkappaBbeta on serines 19 and 23.
196 have identified a hypophosphorylated pool of IkappaBbeta that shields nuclear NF-kappaB from inhibiti
197 phosphatase inhibitors on the proteolysis of IkappaBbeta.
198  Moreover, swapping the N-terminal region of IkappaBbeta for the corresponding IkappaBalpha sequence
199 ch less is known regarding the regulation of IkappaBbeta by NF-kappaB.
200 ere, we describe in detail the regulation of IkappaBbeta by RelA/p65.
201 nsert in regulating cytoplasmic retention of IkappaBbeta.NF-kappaB complexes.
202 esent a necessary but not sufficient role of IkappaBbeta in preventing oxidant stress-induced cell de
203                    Mutations at S313/S315 of IkappaBbeta abolished Cn binding, inhibited Cn-mediated
204 acid, serine, and threonine-rich sequence of IkappaBbeta in proper localization of IkappaBbeta x NF-k
205 that both the N- and C-terminal sequences of IkappaBbeta are required for the inducible degradation o
206 sults suggest that the degradation signal of IkappaBbeta may be controlled by the opposing actions of
207                 The exon/intron structure of IkappaBbeta and IkappaBalpha genes were compared and fou
208                     The crystal structure of IkappaBbeta bound to p65 suggested this complex might bi
209 al domain of IkappaBalpha but not in that of IkappaBbeta or IkappaBepsilon.
210                              Transfection of IkappaBbeta into A549, H441 and K-ras-transformed NIH3T3
211 IkappaBalpha, Tax stimulates the turnover Of IkappaBbeta via a related targeting mechanism.
212 TrCP is also necessary for ubiquitination of IkappaBbeta upon stimulation of cells, and deletion of t
213 ith reduced levels of either IkappaBalpha or IkappaBbeta isoforms.
214  Moreover, overexpression of IkappaBalpha or IkappaBbeta protects endothelial cells from DENV-induced
215 f IkappaBepsilon, but not of IkappaBalpha or IkappaBbeta, are dramatically reduced upon the stimulati
216 eins p65, p50, or p100 or of IkappaBalpha or IkappaBbeta.
217  as mice genetically modified to overexpress IkappaBbeta, we show that nuclear IkappaBbeta is both ne
218 tosis was observed in WT MEFs overexpressing IkappaBbeta with simultaneous IkappaBalpha knockdown, wh
219 1 to regulate IkappaB proteins, particularly IkappaBbeta.
220                               Phosphorylated IkappaBbeta is a substrate for Cn phosphatase, which was
221 rmacologic therapies to specifically prevent IkappaBbeta/NF-kappaB signaling, as well as mice genetic
222 hough the abundance of the inhibitor protein IkappaBbeta was higher in 267B1/Ki-ras cells than in 267
223 ific role of the cRel/p65 inhibitory protein IkappaBbeta was evaluated.
224           SMC express two inhibitor proteins IkappaBbeta and IkappaBalpha.
225 logical roles of the two inhibitory proteins IkappaBbeta and IkappaBalpha.
226 d activation of CnA-sensitive NF-kappaB/Rel (IkappaBbeta-dependent) factors.
227   Deletion of the IkappaBbeta insert renders IkappaBbeta x NF-kappaB complexes capable of shuttling b
228                                 As a result, IkappaBbeta(-/-) mice are resistant to LPS-induced septi
229                   However, the resynthesized IkappaBbeta was in an underphosphorylated state, which a
230  suppresses NF-kappaB activation and retards IkappaBbeta degradation.
231  is based on the ability of p65 to stabilize IkappaBbeta protein from the 26S proteasome, a process m
232 y because of the failure of Tax to stimulate IkappaBbeta gene transcription.
233 xpress IkappaBalpha, but express a T7-tagged IkappaBbeta under the promoter and regulatory sequence o
234                     We also demonstrate that IkappaBbeta mRNA is strongly expressed in developing mal
235                           We have found that IkappaBbeta expression is localized within the haploid s
236                            We show here that IkappaBbeta exists in at least two different forms: one
237     Using p65(-/-) fibroblasts, we show that IkappaBbeta is profoundly reduced in these cells, but no
238 aced with the IkappaBbeta cDNA, we show that IkappaBbeta overexpression prevented oxidative stress-in
239                        This study shows that IkappaBbeta is essential for the propagation of mitochon
240              These observations suggest that IkappaBbeta in the ternary complex is resistant to degra
241         These results therefore suggest that IkappaBbeta may be a novel target for transcription fact
242 whereas MEKK2 participates in assembling the IkappaBbeta:NF-kappaB/IKK complex; these two distinct co
243 nd differences in the mode of binding at the IkappaBbeta sixth ankyrin repeat and NF-kappaB p65 homod
244 ich the IkappaBalpha gene is replaced by the IkappaBbeta cDNA, have uncovered divergent properties of
245                             In contrast, the IkappaBbeta protein can inhibit nuclear import of NF-kap
246 of two basal phosphoacceptors present in the IkappaBbeta PEST domain (Ser-313 and Ser-315) yields a m
247     In this study, we assess the role of the IkappaBbeta insert in regulating cytoplasmic retention o
248                              Deletion of the IkappaBbeta insert renders IkappaBbeta x NF-kappaB compl
249 pendent on the phosphorylation status of the IkappaBbeta PEST domain.
250 equires the PKR-dependent degradation of the IkappaBbeta protein.
251  this signal may affect the stability of the IkappaBbeta protein.
252 h the IkappaBalpha gene is replaced with the IkappaBbeta cDNA, we show that IkappaBbeta overexpressio
253  by replacing the IkappaBalpha gene with the IkappaBbeta gene.
254 G-protein, kappaB-Ras, participates with the IkappaBbeta insert to effectively mask the NF-kappaB nuc
255  multiple Sox binding sites found within the IkappaBbeta promoter and can enhance transcription of a
256                                    Therefore IkappaBbeta acts through p65:c-Rel dimers to maintain pr
257  growth, whereas NF-kappaB signaling through IkappaBbeta degradation mediated apoptosis and P-selecti
258 e stress-induced NF-kappaB signaling through IkappaBbeta would prevent apoptotic cell death.
259 on experiments revealed that, in addition to IkappaBbeta, other IkappaB family members examined (p105
260 e functional fate of NF-kappaB when bound to IkappaBbeta is critically dependent on the phosphorylati
261 on in vivo, whereas replacement of these two IkappaBbeta residues with a phosphoserine mimetic genera
262 a-TrCP abolishes its ability to ubiquitinate IkappaBbeta.
263                                        Using IkappaBbeta knock-in mice (AKBI), in which the IkappaBal
264                  Here we report that in vivo IkappaBbeta serves both to inhibit and facilitate the in
265 etween the strong Ikappa Balpha and the weak IkappaBbeta inhibitors switches their in vivo inhibitory
266 ed by a selective IKKbeta inhibitor, whereas IkappaBbeta degradation was attenuated, suggesting a mec
267 simultaneous IkappaBalpha knockdown, whereas IkappaBbeta overexpression alone did not produce this ef
268 s shuttle in and out of the nucleus, whereas IkappaBbeta x NF-kappaB complexes are retained exclusive
269  turn-off of the NF-kappaB response, whereas IkappaBbeta and - epsilon function to reduce the system'
270 Bbeta, thus highlighting the degree to which IkappaBbeta is dependent on p65.
271                          These findings with IkappaBbeta provide a potential mechanism for the consti
272 ive cells c-Rel is associated primarily with IkappaBbeta, an inhibitory molecule that is not effectiv
273 e that beta-TrCP interacts specifically with IkappaBbeta, and such interaction is dependent on prior

 
Page Top